Advice and challenges in the pharmacotherapeutic management of diabetic kidney disease in adults

Clemens Plattner; Markus Pirklbauer; Gert Mayer

doi:10.1080/14656566.2023.2244420

Advice and challenges in the pharmacotherapeutic management of diabetic kidney disease in adults

Expert Opin Pharmacother. 2023 Sep-Dec;24(16):1747-1752. doi: 10.1080/14656566.2023.2244420. Epub 2023 Aug 21.

Authors

Clemens Plattner¹, Markus Pirklbauer¹, Gert Mayer¹

Affiliation

¹ Department of Internal Medicine IV - Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.

PMID: 37599563
DOI: 10.1080/14656566.2023.2244420

No abstract available

Keywords: Diabetic kidney disease; glucagon-like peptide-1 agonists; non-steroidal mineralocorticoid receptor antagonists; pharmacotherapy; renin–angiotensin system drug effects; sodium-glucose transporter 2 inhibitors.

Publication types

Editorial

MeSH terms

Adult
Diabetes Mellitus, Type 2* / drug therapy
Diabetic Nephropathies* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Mineralocorticoid Receptor Antagonists / therapeutic use
Renal Insufficiency, Chronic* / drug therapy
Renin-Angiotensin System

Substances

Hypoglycemic Agents
Mineralocorticoid Receptor Antagonists